Navigation Links
Teva's Forum Draws Key Pennsylvania Healthcare Leaders
Date:7/30/2009

State Influentials Gather to Discuss the Rising Cost of Medicine for Consumers

PHILADELPHIA, July 30 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today hosted the last in a series of roundtable discussions focused on increasing access to healthcare and affordable medicines in the United States.

The event was held as a part of the company's Year of Affordable Healthcare Campaign (www.yearofaffordablehealth.com), which marks the 25th anniversary of the passing of the Hatch-Waxman Act, a bill which created the modern day pharmaceutical drug industry.

The event featured panelists from around the Philadelphia area, all of whom have distinguished themselves by helping to bring affordable healthcare solutions to the people of Pennsylvania. They included:

  • Thomas Snedden, Director, Pennsylvania Pharmaceutical Assistance Contract for the Elderly
  • Pat Halpin-Murphy, President and Founder, Pennsylvania Breast Cancer Coalition
  • Dr. Janet Young, Medical Director, Greater Philadelphia Health Action, Inc.
  • Donna Duncan, Executive Director, Philadelphia's Linda Creed Breast Cancer Foundation

The panel was moderated by Pam Gilbert, partner at Cuneo Gilbert & LaDuca and former executive director of the Consumer Product Safety Commission.

"We are now at a crucial point in this debate," said Debra Barrett, Senior Vice President of Government Affairs for Teva Pharmaceuticals USA. "Healthcare costs continue to rise and consumers in some cases are struggling to access care. We need to ensure that affordable medicine options like biogenerics are available, so that Pennsylvania citizens don't have to worry about being able to afford their prescriptions."

The spirited discussion centered around the need for healthcare reform, the steadily increasing costs of medicines and treatments and potential solutions for these rising costs -- including the development of a pathway for generic biologic medicines.

About Teva USA

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
3. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
4. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
5. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
6. Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. National Quality Forum Announces New Member Councils Leadership
9. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
10. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
11. SGX Pharmaceuticals to Present at the BIO InvestorForum 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... Lubin Austermuehle, P.C. ... Gather for GRIN2B will be held at Found Kitchen and Social House ... will help fund research on GRIN2B-Related Neurodevelopmental Disorder, a rare condition that results from ...
(Date:9/17/2019)... ... , ... The Center for Information and Study on Clinical ... of The Gift of Participation. Written by CISCRP Founder, Ken Getz, the book ... clinical research process. The new edition offers a fresh look at why participation ...
(Date:9/14/2019)... TULSA, Okla. (PRWEB) , ... September 14, 2019 , ... ... and cannabis industry, has time and again tried to bring the most relevant and ... a ray of hope on an increasingly large number of people across the world ...
(Date:9/11/2019)... ... September 11, 2019 , ... A September 2 ... undergone weight loss surgery were significantly less likely to suffer heart attacks, strokes, kidney ... undergo bariatric surgery. Los Angeles-based weight loss surgery specialists Dr. Feiz and Associates says ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... RMA ... and individuals grow their family, will host a free informational event that will demystify ... food truck meal voucher for the first fifty registrants. The event, “What’s Your Real ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... ... ... year in a row, Mental Health America (MHA) released its annual State ... based on several mental health and access measures. This year, Pennsylvania came out on top ... trends of the last 6 years and shows that many are still not receiving the ...
(Date:9/17/2019)... ... September 17, 2019 , ... Drs. Nickelice Brand and Chris ... placement and restorations in one office. Dental implants are a nearly permanent, comfortable and ... Dental implants have a high success rate when placed by highly trained professionals such ...
(Date:9/17/2019)... , ... September 17, 2019 , ... Embr Labs ... $6M in Series B funding led by DigiTx Partners, with participation from ... Labs will use the investment to grow the company’s footprint in wellness and digital ...
Breaking Medicine Technology: